Parallel Advisors’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
FLAM
GF
VPM
VCM
B
Parallel Advisors's NEO Position: Q1 2026 in Review
Parallel Advisors sold out of NeoGenomics (NEO) in Q1 2026, closing a stake of 144 shares — an estimated $1.69K sold.
Parallel Advisors first reported a position in NEO in Q1 2021 and held it in 20 quarters. The position peaked at $51K in Q3 2021. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.
- Parallel Advisors reported no remaining NeoGenomics position as of Q1 2026 after selling out during the quarter.
- Parallel Advisors sold 144 NeoGenomics shares in Q1 2026, an estimated $1.69K.
- Parallel Advisors first reported a position in NeoGenomics in Q1 2021 and held it in 20 quarters.
- Parallel Advisors's NeoGenomics position peaked at $51K in Q3 2021.
- 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.
Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.